Wom­en's health biotech nabs new an­timi­cro­bial treat­ment; Ovid finds part­ner for neu­ro­science col­lab­o­ra­tion

Daré Bio­science is on the move.

The biotech put out word ear­ly Wednes­day morn­ing that it’s signed a li­cens­ing agree­ment with …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.